FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Philips Wins Clearance for AI-powered Spectral CT System

[ Price : $8.95]

FDA clears a Philips 510(k) for its new Spectral CT Verida system, which the company describes as the first AI-powered detector-ba...

Guidance on Impurity Standards For Fermentation-Based Antibiotics

[ Price : $8.95]

FDA posts a draft guidance outlining how drugmakers should establish impurity specifications for antibiotics produced by fermentat...

FDA Streamlined Compliance Policy for Certain Respirators

[ Price : $8.95]

FDA issues a draft guidance outlining a proposed compliance policy that could ease certain premarket requirements for respirators ...

Opna Bio Wins FDA Fast Track for Multiple Myeloma Drug

[ Price : $8.95]

FDA has granted Opna Bio a fast track designation for its investigational therapy OPN-6602 and its use in treating patients with r...

Collins Presses for Faster Generic Competition at Hearing

[ Price : $8.95]

U.S. Sen. Susan Collins (R-ME) uses a Senate hearing 4/16 to spotlight barriers to lower-cost drugs, pressing an expert witness on...

FDA Satellite Labs Block Illegal Drugs: Batson

[ Price : $8.95]

FDA satellite laboratories branch director JaCinta Batson touts the value of the laboratories work in international mail facilitie...

Phillips Ventilator Correction is Class 1 Recall

[ Price : $8.95]

FDA classifies a correction involving certain ventilators manufactured by Philips as a Class I recall, warning that continued use ...

FDA Seeks Expanded Use of Testosterone Therapies

[ Price : $8.95]

FDA seeks expansion of testosterone replacement therapy use, encouraging drugmakers to explore whether existing products could be ...

White Paper on Improving Accelerated Approval Path

[ Price : $8.95]

An Institute for Clinical and Economic Review white paper states the potential benefits and challenges of several policy changes t...

AdvaMed Recommendations for Class 2 Notification Exemption

[ Price : $8.95]

AdvaMed says it supports FDA efforts to expand exemptions from premarket notification for some Class 2 devices.